Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The primary endpoint was change in bodyweight from baseline at 24 weeks, with 48 weeks included as a secondary outcome
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
Furthermore, the protein levels of progerin, Lamin A/C, and p53 in primary hepatocytes on Day 6 and Day 28 were also predominantly downregulated by IGF-1 overexpression (Fig
If in hot and humid location, follow refrigerator desiccant instructions
.png.jpg)
US$ 23.06
US$ 21.74
US$ 25.88
